Home
Scholarly Works
Results of a phase II study of single-agent...
Conference

Results of a phase II study of single-agent nab-paclitaxel in platinum-refractory second-line metastatic urothelial carcinoma (UC)

Authors

Sridhar SS; Canil CM; Mukherjee SD; Winquist E; Elser C; Eisen A; Reaume MN; Zhang L; Ko Y

Volume

29

Publisher

AMER SOC CLINICAL ONCOLOGY

Publication Date

March 1, 2011

Conference proceedings

JOURNAL OF CLINICAL ONCOLOGY

Issue

7

ISSN

0732-183X

Labels

Fields of Research (FoR)

Contact the Experts team